NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET ...
Merck KGaA's evobrutinib was the first BTK inhibitor to show proof-of-concept in a phase 2 MS trial, but failed two phase 3 trials in relapsing MS last year and was shelved. Novartis' remibrutinib ...
November 25, 2024 • Books We Love returns with 350+ new titles handpicked by NPR staff and trusted critics. Find 12 years of recommendations all in one place — that's nearly 4,000 great reads.
“President Trump, you were born into the world to be a trumpet of God ... When he was 20, he says he had a personal revelation that led him to Jesus, and he eventually became the head of ...